lilly glp-1 drug Eli Lilly's oral pill may help people with Type 2 diabetes lose 'significant' weight, study finds FDA approves new weight-loss pill,

In the 10:10 Menopause Reset Program, Ive had more time to understand how Calocurb can be combined with GLP-1 agonists (weight loss injections), intermittent fasting, the 75/25 plate method, and low histamine eating for women with MCAS

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

With the participation of researchers from the Paul Langerhans Institute Dresden (PLID), partner at the German Center for Diabetes Research, a GLP-1 receptor agonist in the form of tablets could for the first time be compared with the most common second-line therapy of T2D, a DPP-IV inhibitor

Both human and animal studies reported inconsistent BP response to acute administration but showed hypotensive effect of chronic administration of GLP-1/ GLP-1 RAs

Multiple studies highlight its potential applications in prevention

A newly published clinical investigation in the British Journal of Anaesthesia (May 2025 issue) reveals compelling evidence linking glucagon-like peptide-1 receptor agonists (GLP-1RAs) to impaired gastric emptying (IGE)